EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design and Pictet–Spengler enabled synthesis of carboxamide-substituted imidazo[1,2- a ]quinoxalines as dual EGFR and tubulin targeting anticancer agents

Joydeep Chatterjee, Gaurav Joshi, Vibhu Jha iD, Shivkanya M Bhujbal, Shivani Rathour, Sanjana Majumdar, Muhammad Wahajuddin, Prasad V Bharatam, Raj Kumar iD

Journal of Enzyme Inhibition and Medicinal Chemistry · 31.12.2026 · 41 (1)

DOI: 10.1080/14756366.2026.2673744 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Enzyme Inhibition and Medicinal Chemistry, online erschienen am 25.05.2026. Verfasst von Joydeep Chatterjee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University o…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Tubulin, Quinoxalines, Drug Design. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSIR-EMR-II, DST-PURSE, ANRF-SERB.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsTubulinQuinoxalinesDrug DesignTubulin ModulatorsProtein Kinase InhibitorsImidazolesHumansErbB ReceptorsDrug Screening Assays, AntitumorStructure-Activity RelationshipCell ProliferationMolecular StructureDose-Response Relationship, DrugMolecular Docking SimulationAmides

Stichwörter der Autor:innen

EGFR kinase inhibitionROS-mediated apoptosisdual-target anticancer agentsmolecular docking and dynamicstubulin polymerisation

Substanzen

ErbB ReceptorsAntineoplastic AgentsTubulinQuinoxalinesTubulin ModulatorsEGFR protein, humanProtein Kinase InhibitorsImidazolesAmides

Autor:innen und Institutionen

  • Laboratory for Drug Design and Synthesis, Department of Pharmaceutical Sciences and Natural Products, School of Health Sciences, Central University of Punjab, Bathinda, India.
  • Department of Pharmaceutical Science, Hemvati Nandan Bahuguna Garhwal (A Central) University, Srinagar, India.
  • Institute of Cancer Therapeutics, School of Pharmacy, Optometry and Medical Sciences, University of Bradford, Bradford, UK.
  • Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Punjab, India.

ORCID-Profile: Vibhu Jha, Raj Kumar

Förderung

  • CSIR-EMR-II
  • DST-PURSE
  • ANRF-SERB

Zitieren

APA

Chatterjee, J., Joshi, G., Jha, V., Bhujbal, S. M., Rathour, S., Majumdar, S., Wahajuddin, M., Bharatam, P. V., & Kumar, R. (2026). Design and Pictet–Spengler enabled synthesis of carboxamide-substituted imidazo[1,2- a ]quinoxalines as dual EGFR and tubulin targeting anticancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 41(1). https://doi.org/10.1080/14756366.2026.2673744

Vancouver

Chatterjee J, Joshi G, Jha V, Bhujbal SM, Rathour S, Majumdar S, et al. Design and Pictet–Spengler enabled synthesis of carboxamide-substituted imidazo[1,2- a ]quinoxalines as dual EGFR and tubulin targeting anticancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 2026;41(1). doi:10.1080/14756366.2026.2673744

BibTeX
@article{Chatterjee2026,
  author = {Chatterjee, Joydeep and Joshi, Gaurav and Jha, Vibhu and Bhujbal, Shivkanya M and Rathour, Shivani and Majumdar, Sanjana and Wahajuddin, Muhammad and Bharatam, Prasad V and Kumar, Raj},
  title = {Design and Pictet–Spengler enabled synthesis of carboxamide-substituted imidazo[1,2- a ]quinoxalines as dual EGFR and tubulin targeting anticancer agents},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1080/14756366.2026.2673744}
}
Kostenlos starten →